PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
226.29 - 230.79
161.38 - 242.52
38.50M / 42.21M (Avg.)
34.73 | 6.57
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
7.73%
Revenue growth exceeding 1.5x Consumer Cyclical median of 3.84%. Joel Greenblatt would verify if operating margins keep pace with this top-line surge.
-22.59%
Negative gross profit growth while Consumer Cyclical median is 7.11%. Seth Klarman would suspect poor product pricing or inefficient production.
-3.81%
Negative EBIT growth while Consumer Cyclical median is 6.68%. Seth Klarman would check if external or internal factors caused the decline.
4.16%
Operating income growth below 50% of Consumer Cyclical median of 10.73%. Jim Chanos would suspect structural cost disadvantages.
6.05%
Net income growth below 50% of Consumer Cyclical median of 14.42%. Jim Chanos would suspect deeper profitability issues.
5.56%
EPS growth below 50% of Consumer Cyclical median of 13.59%. Jim Chanos would suspect fundamental earnings weakness or heavy dilution.
5.66%
Diluted EPS growth below 50% of Consumer Cyclical median of 15.17%. Jim Chanos would suspect fundamental profit weaknesses or heavy share issuance.
0.32%
Share change of 0.32% while Consumer Cyclical median is zero. Walter Schloss would see if the modest difference matters long-term.
0.12%
Diluted share change of 0.12% while Consumer Cyclical median is zero. Walter Schloss might see a slight difference in equity issuance policy.
No Data
No Data available this quarter, please select a different quarter.
91.10%
OCF growth of 91.10% while Consumer Cyclical is zero. Walter Schloss might see a modest positive difference, which can compound over time.
104.15%
FCF growth of 104.15% while Consumer Cyclical median is zero. Walter Schloss might see a slight edge that could compound over time.
535.12%
10Y revenue/share CAGR exceeding 1.5x Consumer Cyclical median of 43.57%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
77.32%
5Y revenue/share growth exceeding 1.5x Consumer Cyclical median of 22.10%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
32.32%
3Y revenue/share growth exceeding 1.5x Consumer Cyclical median of 12.38%. Joel Greenblatt might see a short-term competitive advantage at play.
1329.66%
OCF/share CAGR of 1329.66% while Consumer Cyclical median is zero. Walter Schloss might see a modest edge that can add up if momentum improves.
48.34%
OCF/share CAGR of 48.34% while Consumer Cyclical median is zero. Walter Schloss might see a slight advantage that can compound if momentum builds.
246.94%
3Y OCF/share growth of 246.94% while Consumer Cyclical median is zero. Walter Schloss might see a modest advantage that could compound if momentum holds.
17236.10%
Net income/share CAGR exceeding 1.5x Consumer Cyclical median of 35.20% over a decade. Joel Greenblatt might see a standout compounder of earnings.
225.70%
5Y net income/share CAGR > 1.5x Consumer Cyclical median of 23.43%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
956.76%
3Y net income/share CAGR of 956.76% while Consumer Cyclical median is zero. Walter Schloss might see a small advantage that can be scaled further.
2390.46%
Equity/share CAGR exceeding 1.5x Consumer Cyclical median of 15.33% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
325.60%
5Y equity/share CAGR > 1.5x Consumer Cyclical median of 16.86%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
142.98%
3Y equity/share CAGR > 1.5x Consumer Cyclical median of 9.18%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.90%
Receivables growth far exceeding Consumer Cyclical median. Jim Chanos suspects potential red flags in revenue quality.
13.83%
Inventory growth far above Consumer Cyclical median. Jim Chanos suspects major issues in demand forecasting or potential obsolescence risk.
6.05%
Asset growth exceeding 1.5x Consumer Cyclical median of 0.66%. Joel Greenblatt confirms strong expansions matched by adequate returns on those assets.
8.78%
BV/share growth exceeding 1.5x Consumer Cyclical median. Joel Greenblatt checks if consistent ROE or undervalued buybacks fuel this advantage.
0.52%
Slightly rising debt while Consumer Cyclical median is deleveraging. Peter Lynch wonders if the firm lags behind peers in risk control or invests in more expansions.
18.14%
R&D growth of 18.14% while Consumer Cyclical median is zero. Walter Schloss wonders if a slight increase yields a meaningful competitive edge.
16.06%
SG&A growth far above Consumer Cyclical median. Jim Chanos sees potential red flags in cost management or diminishing returns on spending.